Kalcipos

Calcium, the active ingredient in Kalcipos, is a calcium supplement presented as an oral tablet for oral use. It supports bone mineralization and helps correct calcium deficiency in the general population. GNH USA supplies Kalcipos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kalcipos is a calcium supplement that acts on mineral metabolism and bone health. - Osteopenia: helps maintain bone density and reduce progression to osteoporosis. - Calcium deficiency: restores normal serum calcium levels in individuals with inadequate dietary intake. - Postmenopausal bone health: contributes to bone mineralization during the post‑menopausal period.

Kalcipos is generally well tolerated, but some users may experience mild reactions.

Common Side Effects: - Constipation: occasional difficulty passing stools. - Nausea: mild stomach upset after ingestion. - Abdominal discomfort: transient bloating or cramping. - Flatulence: increased gas production. - Metallic taste: brief alteration of taste perception. - Increased thirst: sensation of dry mouth.

Serious or Rare Side Effects: - Hypercalcemia: elevated blood calcium that may cause weakness or cardiac arrhythmia. - Kidney stones: formation of calcium‑based calculi in susceptible individuals. - Allergic reaction: rash, itching, or swelling of the face, lips, or tongue. - Severe hypotension: sudden drop in blood pressure in rare cases. - Cardiac arrhythmia: irregular heart rhythm associated with high calcium levels.

Before using Kalcipos, consider the following safety measures. - Assess dietary calcium: evaluate total calcium intake from food and other supplements. - Monitor serum calcium: periodic blood tests are advisable for patients at risk of hypercalcemia. - Use with vitamin D: ensure adequate vitamin D status to facilitate calcium absorption. - Avoid in hypercalcemia: contraindicated for individuals with known elevated calcium levels. - Caution in renal impairment: adjust dosage and monitor kidney function. - Pregnancy and lactation: safety not established; consult a healthcare professional. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Kalcipos can affect or be affected by other medicines.

Major Interactions (Avoid): - Bisphosphonates: calcium reduces oral absorption; separate dosing by at least 2 hours. - Tetracycline antibiotics: calcium chelates the drug, lowering its effectiveness. - Iron supplements: concurrent intake impairs calcium absorption. - Thiazide diuretics: may increase serum calcium and risk of hypercalcemia.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: potential additive effect on calcium levels. - Digoxin: high calcium may increase digoxin toxicity. - Levothyroxine: calcium can decrease thyroid hormone absorption; monitor thyroid function tests.